Favorable policies support biopharmaceutical stocks
Updated: 2013-02-08 13:58
(China Daily)
|
||||||||
China's encouraging policies for the biological industry are supporting the biopharmaceutical sector's share prices, industry observers said.
The National Development and Reform Commission, China's top economic planner, issued its 12th Five-Year Development Plan for the Biological Industry early last month, showing that the biological pharmaceutical sector is one of the seven key industries that China will support by 2020.
The plan stipulates that the annual growth of the sector should be 20 percent in the coming three years. The average increase in the biopharmaceutical sector's stock prices was estimated at 2 percent on the Shanghai Stock Exchange last month.
- Li Na on Time cover, makes influential 100 list
- FBI releases photos of 2 Boston bombings suspects
- World's wackiest hairstyles
- Sandstorms strike Northwest China
- Never-seen photos of Madonna on display
- H7N9 outbreak linked to waterfowl migration
- Dozens feared dead in Texas plant blast
- Venezuelan court rules out manual votes counting
Most Viewed
Editor's Picks
American abroad |
Industry savior: Big boys' toys |
New commissioner
|
Liaoning: China's oceangoing giant |
TCM - Keeping healthy in Chinese way |
Poultry industry under pressure |
Today's Top News
Boston bombing suspect reported cornered on boat
7.0-magnitude quake hits Sichuan
Cross-talk artist helps to spread the word
'Green' awareness levels drop in Beijing
Palace Museum spruces up
First couple on Time's list of most influential
H7N9 flu transmission studied
Trading channels 'need to broaden'
US Weekly
Beyond Yao
|
Money power |